Nursing Exams: NCLEX-RN NCLEX-PN TEAS HESI Online Tutoring
Contrary to what Hollywood blockbusters lead you to expect, Americans should focus less on the remote possibility of a civilization-destroying viral epidemic and worry a whole lot more about the real-life army of deadly superbugs lurking beneath hospital beds, re-colonizing improperly sterilized surgical equipment, and running rampant in ER waiting rooms and hospital wards throughout the country.
Hospital-associated infections (HAIs) now affect a staggering one in twenty patients in the US, and are estimated to cause more than 100,000 deaths each year. The World Health Organization reports that at any given time, 1.4 million people are battling infections or complications resulting from hospitalization.
One of the deadliest superbugs of all, MRSA, is transmitted in hospitals at an alarming rate as it is now resistant to penicillin and many of the newer antibiotics as well. So, it is with an enormous sense of relief that a real glimmer of hope in the war against HAIs has finally begun to emerge on the health care horizon. A new decontamination and disinfection technology developed by Medizone International and boasting an unprecedented 99.9999 percent microbial kill rate, looks set to one day make our hospitals safer again.
The bacteria-destroying product known as AsepticSure has been clinically proven to quickly and safely decontaminate all surfaces in a hospital setting and even purify the air during the process.
AsepticSure has encouraging potential for any health care environment as it is capable of wiping out almost all disease-related pathogens from public and private hospitals, nursing homes, medical centers and even day care centers. Nothing else comes close to AsepticSure’s level of microbial eradication.
“There is no virus, to our knowledge, that could survive our protocol. If the protocol can achieve 100 percent kill with spore-forming bacteria such as C. difficile, it will definitely kill all viruses,” affirms Medizone’s President and Director of Medical Affairs Dr. Michael Shannon.
AsepticSure could significantly reduce hospital-acquired infections just as soon as the health care industry sits up and takes notice of how beneficial the technology is. Given that HAIs are among the leading causes of death in the U.S. costing around $33 billion dollars in additional patient costs, early adoption of AsepticSure can’t come soon enough.
Superbugs are elusive, adaptable, vicious and deadly; that’s why we need a formidable antibacterial Goliath on our side, too.
To learn more about AsepticSure, visit medizoneint.com
Forensic Nursing Chronicles 